Clinical Trial Update: Clinical Outcomes From Nalmefene [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating nalmefene for opioid overdose has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Overdose

Drugs mentioned

• Nalmefene (nalmefene)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Opioid Overdose | Phase 4 | Status: WITHDRAWN